Literature DB >> 8199993

Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections.

L M Cohen1, M W McCall, S J Hodge, J D Freedman, J P Callen, R H Zax.   

Abstract

BACKGROUND: Lentigo maligna (LM) is a pigmented neoplasm on sun-exposed skin of elderly patients. LM slowly increases in size and may become lentigo maligna melanoma (LMM), a potentially fatal malignancy. Complete excision is the treatment of choice. Mohs' micrographic surgery (MMS) with frozen and permanent sections may be used for complete eradication of the lesion, while sparing as much normal tissue as possible. The authors studied the efficacy of MMS for the treatment of LM and LMM.
METHODS: Between 1985 and 1992, 45 patients with LM (26) and LMM (19) were treated with MMS. The authors' technique was to use examination of frozen sections and rush permanent sections (prepared and read within 24 hours). Positive frozen sections warranted further excision. For negative or equivocal frozen sections, surgery was interrupted until the examination of permanent sections was performed.
RESULTS: All 45 patients were free of local disease and evidence of metastases at an average of 29.2 months (range, 4-81 months) after therapy.
CONCLUSIONS: MMS aided by rush permanent sections yielded a prolonged disease free survival for all 45 patients with LM or LMM. Because the MMS technique minimizes the removal of normal tissue, and the local cure rate in this study was superior to that reported for conventional surgery, the authors recommend this technique for the treatment of LM and LMM.

Entities:  

Mesh:

Year:  1994        PMID: 8199993     DOI: 10.1002/1097-0142(19940615)73:12<2964::aid-cncr2820731213>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Management of cutaneous tumors with mohs micrographic surgery.

Authors:  Krisinda C Dim-Jamora; Jennifer B Perone
Journal:  Semin Plast Surg       Date:  2008-11       Impact factor: 2.314

2.  An extrafacial amelanotic lentigo maligna of the leg: a case report.

Authors:  Antonella Tammaro; Diego Orsini; Alessandra Narcisi; Giorgia Cortesi; Francesca R Parisella; Veronica Giulianelli; Claudia Abruzzese; Severino Persechino
Journal:  Int Wound J       Date:  2014-08-14       Impact factor: 3.315

Review 3.  Primary Melanoma: from History to Actual Debates.

Authors:  Alessandro A E Testori; Stephanie A Blankenstein; Alexander C J van Akkooi
Journal:  Curr Oncol Rep       Date:  2019-12-19       Impact factor: 5.075

4.  Melanoma in Situ Treated with Topical Imiquimod for Management of Persistently Positive Margins: A Review of Treatment Methods.

Authors:  Qing Fan; Stephanie Cohen; Becky John; Adam I Riker
Journal:  Ochsner J       Date:  2015

5.  Incidence of lentigo maligna in Olmsted County, Minnesota, 1970 to 2007.

Authors:  Sultan A Mirzoyev; Richelle M Knudson; Kurtis B Reed; Jennifer L Hou; Christine M Lohse; Marcus L Frohm; Jerry D Brewer; Clark C Otley; Randall K Roenigk
Journal:  J Am Acad Dermatol       Date:  2013-12-24       Impact factor: 11.527

6.  Lentigo Maligna of the head and neck: A retrospective study assessing surgical excision margins in a South African population.

Authors:  Johann de Wet; Pieter J du Plessis; Johann W Schneider
Journal:  JAAD Int       Date:  2022-04-28

Review 7.  Current perspectives on Mohs micrographic surgery for melanoma.

Authors:  Derek Beaulieu; Ramin Fathi; Divya Srivastava; Rajiv I Nijhawan
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-06-20

Review 8.  Surgery and radiotherapy in the treatment of cutaneous melanoma.

Authors:  A Testori; P Rutkowski; J Marsden; L Bastholt; V Chiarion-Sileni; A Hauschild; A M M Eggermont
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

9.  Surgery of primary melanomas.

Authors:  Piotr Rutkowski; Marcin Zdzienicki; Zbigniew I Nowecki; Alexander C J Van Akkooi
Journal:  Cancers (Basel)       Date:  2010-05-11       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.